Clinical observation of CHOP regimen and CHOEP regimen in the treatment of Non-Hodgkin’s lymphoma
WU Xiang-cheng
Abstract
WU Xiang-cheng
Abstract
To observe the effect and toxicity of biweekly CHOP regimen and CHOEP regimen in the treatment of Non-Hodgkin’s lymphoma.Fifty-one case of NHL were randomly allocated into three groups: Patients respectively received standard CHOP, CHOEP and CHOP-14 regimen, we observe the effect and toxicity.Of 50 cases,29 received CR, 16 received PR, Overall response (OR) rates were 88.2% (CR+PR),CR and OR were 50.0% and 85.0% ,respectively, for CHOP, 56.0% and 87.5%, respectively, for CHOEP and 66.7% and 93.3%, respectively, for CHOP-14,there were a good tendency for patients treated with CHOEP and CHOP-14 regimen, while there were no significantly difference for CR ,OR and toxicity among three groups.CHOEP and CHOP-14 should be considered safe and effective chemotherapy regimens for patients with Non-Hodgkin’s lymphoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To observe the effect and toxicity of biweekly CHOP regimen and CHOEP regimen in the treatment of Non-Hodgkin’s lymphoma.Fifty-one case of NHL were randomly allocated into three groups: Patients respectively received standard CHOP, CHOEP and CHOP-14 regimen, we observe the effect and toxicity.Of 50 cases,29 received CR, 16 received PR, Overall response (OR) rates were 88.2% (CR+PR),CR and OR were 50.0% and 85.0% ,respectively, for CHOP, 56.0% and 87.5%, respectively, for CHOEP and 66.7% and 93.3%, respectively, for CHOP-14,there were a good tendency for patients treated with CHOEP and CHOP-14 regimen, while there were no significantly difference for CR ,OR and toxicity among three groups.CHOEP and CHOP-14 should be considered safe and effective chemotherapy regimens for patients with Non-Hodgkin’s lymphoma.
Key concepts: Regimen, CHOP, Medicine, Lymphoma, Internal medicine, Toxicity, Chemotherapy, Gastroenterology